Welcome to LookChem.com Sign In|Join Free

CAS

  • or

2719-32-6

Post Buying Request

2719-32-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2719-32-6 Usage

Description

4-CYANOPHENYL ISOTHIOCYANATE, also known as p-Cyanophenyl Isothiocyanate, is a synthetic isothiocyanate derivative characterized by its light yellow to beige crystalline powder appearance. It possesses potential anti-NF-kB and anti-inflammatory activities, making it a promising compound for various applications in different industries.

Uses

Used in Pharmaceutical Industry:
4-CYANOPHENYL ISOTHIOCYANATE is used as a pharmaceutical compound for its potential anti-NF-kB and anti-inflammatory properties. It can be utilized in the development of drugs targeting inflammation-related diseases and conditions.
Used in Research and Development:
In the research and development sector, 4-CYANOPHENYL ISOTHIOCYANATE serves as a valuable chemical for studying the mechanisms of NF-kB inhibition and inflammation. It can be used to develop new therapeutic strategies and understand the underlying pathways involved in these processes.
Used in Chemical Synthesis:
4-CYANOPHENYL ISOTHIOCYANATE can be employed as a synthetic building block or intermediate in the production of other related compounds with potential applications in various industries, such as agriculture, materials science, and environmental science.
Used in Analytical Chemistry:
As a light yellow to beige crystalline powder, 4-CYANOPHENYL ISOTHIOCYANATE can be used in analytical chemistry for the detection, identification, and quantification of specific compounds or substances due to its unique chemical properties.

Check Digit Verification of cas no

The CAS Registry Mumber 2719-32-6 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,7,1 and 9 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 2719-32:
(6*2)+(5*7)+(4*1)+(3*9)+(2*3)+(1*2)=86
86 % 10 = 6
So 2719-32-6 is a valid CAS Registry Number.
InChI:InChI=1/C8H4N2S/c9-5-7-1-3-8(4-2-7)10-6-11/h1-4H

2719-32-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (L10173)  4-Cyanophenyl isothiocyanate, 98%   

  • 2719-32-6

  • 1g

  • 251.0CNY

  • Detail
  • Alfa Aesar

  • (L10173)  4-Cyanophenyl isothiocyanate, 98%   

  • 2719-32-6

  • 5g

  • 819.0CNY

  • Detail
  • Alfa Aesar

  • (L10173)  4-Cyanophenyl isothiocyanate, 98%   

  • 2719-32-6

  • 25g

  • 3288.0CNY

  • Detail
  • Aldrich

  • (484660)  4-Cyanophenylisothiocyanate  98%

  • 2719-32-6

  • 484660-2G

  • 545.22CNY

  • Detail

2719-32-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-isothiocyanatobenzonitrile

1.2 Other means of identification

Product number -
Other names Benzonitrile,4-isothiocyanato

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2719-32-6 SDS

2719-32-6Relevant articles and documents

Cascade radical reaction of 2-alkynyl-substituted aryl radicals with aryl isothiocyanates: A novel entry to benzothieno[2,3-b]quinolines through α-(arylsulfanyl)imidoyl radicals

Benati,Leardini,Minozzi,Nanni,Spagnolo,Zanardi

, p. 8669 - 8674 (2000)

The novel cascade radical reaction of 2-(phenylalkynyl)aryl radicals with 4-Y-phenyl isothiocyanates (Y = H, OMe, Me, Cl, CN) provides a useful one-pot protocol for the production of 8-Y-substituted (12) and/or 9-Y-substituted benzothieno[2,3-b]quinolines (11). The whole process entails primary formation of an α-(2-alkynylarylsulfanyl)imidoyl radical that undergoes smooth 5-exo-dig cyclization onto the alkynyl triple bond. The derived 1-phenylvinyl radical then exhibits six-membered cyclization onto the isothiocyanate ring, to give 11, and/or five-membered ipso-cyclization to an azaspiro intermediate, whose eventual rearrangement affords 12. The overall findings clearly showed that the relative proportion of the outcoming isomeric benzothienoquinolines 11 and 12 can be markedly affected by the nature of the original isothiocyanate substituent. Moreover, the findings also furnished the first chemical evidence that enhancing the electrophilic power of the employed radical can properly enhance the reactivity of aryl radicals toward isothiocyanates.

Iron-promoted one-pot approach: Synthesis of isothiocyanates

Pendem, Venkata Bhavanarushi,Nannapaneni, Madhavi

, p. 485 - 490 (2020/02/18)

We have established a facile and versatile synthesis for the construction of isothiocyanates from their respective amines in the presence of an eco-friendly, inexpensive, easily available Iron catalyst under mild conditions. This reaction provides the target products through the formation of thiocarbamate salt as an intermediate. Both aromatic amines and aliphatic amines provided the respective target products in moderate to high yield under optimized reaction conditions. However, electron withdrawing substituents were difficult to give target product at room temperature, whereas, they obtained final products in good yield at moderate temperature. In addition, mechanistic studies were revealed that the synthetic route involved iron based subsequent reactions of addition and removal of sulfur.

2-Aminothiazole Derivatives as Selective Allosteric Modulators of the Protein Kinase CK2. 2. Structure-Based Optimization and Investigation of Effects Specific to the Allosteric Mode of Action

Bestgen, Beno?t,Kufareva, Irina,Seetoh, Weiguang,Abell, Chris,Hartmann, Rolf W.,Abagyan, Ruben,Le Borgne, Marc,Filhol, Odile,Cochet, Claude,Lomberget, Thierry,Engel, Matthias

, p. 1817 - 1836 (2019/02/26)

Protein CK2 has gained much interest as an anticancer drug target in the past decade. We had previously described the identification of a new allosteric site on the catalytic α-subunit, along with first small molecule ligands based on the 4-(4-phenylthiazol-2-ylamino)benzoic acid scaffold. In the present work, structure optimizations guided by a binding model led to the identification of the lead compound 2-hydroxy-4-((4-(naphthalen-2-yl)thiazol-2-yl)amino)benzoic acid (27), showing a submicromolar potency against purified CK2α (IC50 = 0.6 μM). Furthermore, 27 induced apoptosis and cell death in 786-O renal cell carcinoma cells (EC50 = 5 μM) and inhibited STAT3 activation even more potently than the ATP-competitive drug candidate CX-4945 (EC50 of 1.6 μM vs 5.3 μM). Notably, the potencies of our allosteric ligands to inhibit CK2 varied depending on the individual substrate. Altogether, the novel allosteric pocket was proved a druggable site, offering an excellent perspective to develop efficient and selective allosteric CK2 inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 2719-32-6